Elizabeth E. Evans Net Worth

Ms. Elizabeth E. Evans biography

Elizabeth E. Evans is the COO and Sr. VP of Discovery & Translational Medicine at Vaccinex Inc.

How old is Ms Evans?

Ms Evans is 49, she's been the COO and Sr. VP of Discovery & Translational Medicine of Vaccinex Inc since . There are 3 older and 2 younger executives at Vaccinex Inc. The oldest executive at Vaccinex Inc is John E. Leonard Ph.D., 75, who is the Sr. VP of Devel..

What's Ms Evans's mailing address?

Elizabeth's mailing address filed with the SEC is C/O VACCINEX, INC., 1895 MOUNT HOPE AVENUE, ROCHESTER, NY, 14620.

Insiders trading at Vaccinex Inc

Over the last 6 years, insiders at Vaccinex Inc have traded over $3,161 worth of Vaccinex Inc stock and bought 14,062,785 units worth $29,583,294 . The most active insiders traders include Albertfcmi Parent Co. Fried..., Maurice Zauderer és Maurice Vaccinex (Rochester.... On average, Vaccinex Inc executives and independent directors trade stock every 61 days with the average trade being worth of $2,417,268. The most recent stock trade was executed by Albertfcmi Parent Co. Fried... on 9 August 2024, trading 100 units of VCNX stock currently worth $451.

What does Vaccinex Inc do?

located in rochester, ny, vaccinex is a privately held, clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal antibodies, therapeutic vaccines and other biologic products to treat serious diseases with unmet needs, including cancer, multiple sclerosis, and other autoimmune diseases. we conduct discovery research in-house and in collaboration with world-class academic institutions and biotechnology companies, and have an experienced in-house drug development management team to advance our pre-clinical and clinical stage biopharmaceutical development programs. our development team is led by seasoned industry veterans with both operational and executive level biopharmaceutical industry experience in therapeutic biologics research, manufacturing, quality assurance, quality control, toxicology, pharmacology, drug regulatory affairs, and clinical affairs. we are committed to innovation in the way we approach drug discovery and develop

Vaccinex Inc executives and stock owners

Vaccinex Inc executives and other stock owners filed with the SEC include:

• Dr. Maurice Zauderer Ph.D.,
  Co-Founder, CEO, Pres & Director
• Dr. Ernest S. Smith Ph.D.,
  Sr. VP of Research & Chief Scientific Officer
• Scott E. Royer C.F.A., M.B.A.,
  Chief Financial Officer
• Dr. John E. Leonard Ph.D.,
  Sr. VP of Devel.
• Dr. Elizabeth E. Evans Ph.D.,
  COO and Sr. VP of Discovery & Translational Medicine
• Elizabeth E. Evans,
  COO and Sr. VP of Discovery & Translational Medicine
• John E. Leonard Ph.D.,
  Sr. VP of Devel.
• Dr. Deepak M. Sahasrabudhe,
  Co-Founder, Sr. Mang. of Laboratory Operations & Safety and Scientific & Clinical Advisor
• Maurice Vaccinex (Rochester...,
  President and CEO
• Jill Sanchez,
  Chief Financial Officer
• Albert Vaccinex (Rochester)...,
  
• Bala S Manian,
  Director
• Jeff Goater,
  Director
• Albertfcmi Parent Co. Fried...,
  
• Robert Scala,
  Chief Commercial Officer
• Jacob B. Frieberg,
  Director
• Raymond E. Watkins,
  SVP & Chief Operating Officer
• Barbara Yanni,
  Director
• Alejandro M. Berlin,
  Director
• Inc. Vaccinex,,
  Director
• Ernest S. Smith,
  SVP, Research & CSO
• John E. Leonard,
  SVP, Development
• Scott E. Royer,
  Chief Financial Officer
• Strydonck, Gerald E. Van,
  Director
• Elizabeth E. Evans,
  Chief Operating Officer
• Maurice Zauderer,
  President and CEO